PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETER MARKET ANALYSIS

Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market, by Product Type (Normal Balloon Catheter, Drug Eluting Balloon Catheter, Cutting Balloon Catheter, and Scoring Balloon Catheter), by Balloon Material (Polyolefin copolymer (POC), Polyethylene (PE), and Polyethylene terephthalate (PET)), by End User (Hospitals and Ambulatory Surgical Centers) by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Aug 2022
Code : CMI5194
Pages :180
Formats :
Excel and PDF
Industry : Medical Devices

Market Challenges And Opportunities

Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market Restraint

Increasing product recalls are expected to hinder the growth of the percutaneous transluminal coronary angioplasty (PTCA) balloon catheter market over the forecast period. For instance, in February 2020, Abbott, a medical device and healthcare company, had voluntarily recalled specific lots of two types of its coronary angioplasty catheters – NC Trek RX Coronary Dilatation Catheter and NC Traveler Coronary Dilatation Catheter, as the balloons from the impacted lots may not deflect as intended, and the U.S Food and Drug Administration has classified this as Class I recall.

Restraints & Challenges: